saikosaponin d has been researched along with Lung Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Guo, Q; Hu, C; Liang, Y; Wang, W; Yang, L | 1 |
| Chen, W; Liu, K; Ren, F; Wu, H; Wu, S; Xu, F; Zheng, D | 1 |
| Chen, X; Liu, C; Wu, J; Ying, M; Zhao, P; Zhao, R; Zhou, N | 1 |
| Hsu, YL; Kuo, PL; Lin, CC | 1 |
4 other study(ies) available for saikosaponin d and Lung Neoplasms
| Article | Year |
|---|---|
Saikosaponin-D induces the pyroptosis of lung cancer by increasing ROS and activating the NF-κB/NLRP3/caspase-1/GSDMD pathway.
Topics: Acetylcysteine; Carcinoma, Non-Small-Cell Lung; Caspase 1; Humans; Inflammasomes; Lung Neoplasms; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Pyroptosis; Reactive Oxygen Species; Tumor Microenvironment | 2023 |
Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Oleanolic Acid; Saponins; STAT3 Transcription Factor | 2020 |
Synergetic and Antagonistic Molecular Effects Mediated by the Feedback Loop of p53 and JNK between Saikosaponin D and SP600125 on Lung Cancer A549 Cells.
Topics: A549 Cells; Anthracenes; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Drug Synergism; Feedback, Physiological; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Oleanolic Acid; Phosphorylation; Saponins; Tumor Suppressor Protein p53 | 2018 |
The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Lung Neoplasms; Medicine, Chinese Traditional; Membrane Glycoproteins; Oleanolic Acid; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reagent Kits, Diagnostic; Saponins; Tumor Suppressor Protein p53 | 2004 |